[Clinical study of Wenxikeli treatment of viral myocarditis].
OBJECTIVE
To observe Wenxinkeli viral myocarditis clinical efficacy and safety.


METHODS
45 patients were randomly divided into two groups. Treatment group given Wenxinkeli (5 g, 3 times a day with warm water) treatment, the control group given adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs, treatment for 4 weeks.


RESULTS
The treatment of clinical symptoms, signs and ECG improvement, restoration of enzyme than the control group, there was a significant difference (P < 0.05).


CONCLUSIONS
Wenxinkeli ventricular premature treatment of viral myocarditis is effective, and no significant adverse reactions, safety, good.
Sun
Hong-yan
HY
The People's Liberation Army, General Hospital, The First Affiliated Hospital of Heart Medicine, Beijing 100037, China.
D000293:Adolescent; D000328:Adult; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000188:drug therapy* / Q000821:virology*; D016896:Treatment Outcome; D055815:Young Adult
D004365:Drugs, Chinese Herbal